Skip to main content
Journal cover image

Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves.

Publication ,  Journal Article
Pandey, AK; Xu, K; Zhang, L; Gupta, S; Eikelboom, J; Lopes, RD; Crowther, M; Belley-Côté, EP; Whitlock, RP
Published in: J Thromb Thrombolysis
April 2022

The optimal INR target in patients with mechanical heart valves is unclear. Higher INR targets are often used in Western compared with East Asian countries. The objective of this systematic review and meta-analysis was to summarize the evidence for the efficacy and safety of lower versus higher INR targets in Western and East Asian left-sided mechanical heart valve patients. We searched Western databases including Cochrane CENTRAL, Medline, and Embase as well as Chinese databases including SinoMed, CNKI, and Wanfang Data in addition to grey literature for Randomized Controlled Trials (RCTs) and observational studies. We pooled risk ratios (RRs) using random-effects model. Low and high INR targets were defined by the individual studies. We identified nine RCTs, including six Western (n = 5496) and three East Asian (n = 209) trials, and 17 observational studies, including two Western (n = 3199) and 15 East Asian (n = 5485) studies. In the RCTs, lower compared with higher targets were associated with similar rates of thromboembolism (2.4 vs. 2.3%; RR: 1.14, 95% CI 0.82, 1.60, I2 = 0%) and lower rates of both total bleeding (21.9 vs. 40.9%, RR: 0.46, 95% CI 0.28, 0.78, I2 = 88%) and major bleeding. RCT data showed no statistical heterogeneity by region. These effects were consistent in the observational data. We downgraded the quality of evidence due to serious risk of bias and imprecision. In patients with left-sided contemporary mechanical heart valves, low quality evidence suggests lower INR targets are associated with similar rates of thromboembolism and moderate quality evidence suggests lower rates of bleeding.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Thromb Thrombolysis

DOI

EISSN

1573-742X

Publication Date

April 2022

Volume

53

Issue

3

Start / End Page

697 / 707

Location

Netherlands

Related Subject Headings

  • Vitamin K
  • Thromboembolism
  • Humans
  • Hemorrhage
  • Heart Valves
  • Fibrinolytic Agents
  • Cardiovascular System & Hematology
  • Anticoagulants
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pandey, A. K., Xu, K., Zhang, L., Gupta, S., Eikelboom, J., Lopes, R. D., … Whitlock, R. P. (2022). Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves. J Thromb Thrombolysis, 53(3), 697–707. https://doi.org/10.1007/s11239-021-02568-3
Pandey, Arjun K., Ke Xu, Li Zhang, Saurabh Gupta, John Eikelboom, Renato D. Lopes, Mark Crowther, Emilie P. Belley-Côté, and Richard P. Whitlock. “Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves.J Thromb Thrombolysis 53, no. 3 (April 2022): 697–707. https://doi.org/10.1007/s11239-021-02568-3.
Pandey AK, Xu K, Zhang L, Gupta S, Eikelboom J, Lopes RD, et al. Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves. J Thromb Thrombolysis. 2022 Apr;53(3):697–707.
Pandey, Arjun K., et al. “Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves.J Thromb Thrombolysis, vol. 53, no. 3, Apr. 2022, pp. 697–707. Pubmed, doi:10.1007/s11239-021-02568-3.
Pandey AK, Xu K, Zhang L, Gupta S, Eikelboom J, Lopes RD, Crowther M, Belley-Côté EP, Whitlock RP. Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves. J Thromb Thrombolysis. 2022 Apr;53(3):697–707.
Journal cover image

Published In

J Thromb Thrombolysis

DOI

EISSN

1573-742X

Publication Date

April 2022

Volume

53

Issue

3

Start / End Page

697 / 707

Location

Netherlands

Related Subject Headings

  • Vitamin K
  • Thromboembolism
  • Humans
  • Hemorrhage
  • Heart Valves
  • Fibrinolytic Agents
  • Cardiovascular System & Hematology
  • Anticoagulants
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology